May 2 - Linda M. Liau, distinguished UCLA professor, neurosurgeon, and brain tumor expert, who served as the principal investigator for Northwest Biotheraputics’ DCVax-L phase III study, speaking at AANS (American Association of Neurological Surgeons) re Glioblastoma. - https://t.co/uizFandHtV
May 10 - Linda M. Liau speaking at The New York Academy of Science's Frontiers in Cancer Immunotherapy Conference re "Autologous Tumor Lysate-loaded Dendritic Cell Vaccination for Glioblastoma" - https://t.co/LjNhhhQ5HU
May 18: last year's ASM (Annual Shareholders Meeting) was on May 18th; this year's has not yet been announced, and so there's speculation that it'll be after ASCO (American Society of Clinical Oncology) conference
June 4 - Marnix Bosch, PhD, Chief Technical Officer, Northwest Biosciences, will speak at ASCO (3:00 PM–4:00 PM) re: Dendritic Cell Vaccines for Cancer, and personalized dendritic cell cancer vaccines. - https://conferences.asco.org/am/industry-expert-theater
June 30 - last possible day for ASM according to the following: “no later than 15 months after holding the last preceding annual meeting, but no later than six months after the end of its preceding financial year". NWBO's fiscal year-end is Dec 31, so July 1 would be the 6 months after, or May 18 + 15mo is Aug 18th so it would have to be before July 1st. And they have to give us 10 days notice minimum.
July 23 - interest payments begin on $15 million loan - https://nwbio.com/northwest-biotherapeutics-announces-15-million-financing/
$NWBO dates
May 2 - Linda Liau at AANS re Glioblastoma
May 10 - Linda Liau at NYAS re "Autologous Tumor Lysate-loaded Dendritic Cell Vaccination for Glioblastoma"
May 18 - last year's ASM; this year's not yet announced